| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.89.1.52 |
| P8608 | Fatcat ID | release_wukfeqebkvae5jp4amacfutqle |
| P698 | PubMed publication ID | 8281693 |
| P5875 | ResearchGate publication ID | 14916987 |
| P50 | author | Steven E. Reis | Q47700105 |
| P2093 | author name string | Zacur HA | |
| Blumenthal RS | |||
| Resar JR | |||
| Brinker JA | |||
| Gerstenblith G | |||
| Gloth ST | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 52-60 | |
| P577 | publication date | 1994-01-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. | |
| P478 | volume | 89 |
| Q71776398 | 17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X |
| Q77725789 | 17Beta-estradiol acutely improves endothelium-dependent relaxation to bradykinin in isolated human coronary arteries |
| Q35589198 | 17Beta-estradiol effects on human coronaries and grafts employed in myocardial revascularization: a preliminary study |
| Q31834405 | 17beta-estradiol increases nitric oxide-dependent dilation in rat pulmonary arteries and thoracic aorta |
| Q43917968 | A placebo-controlled trial of long-term oral combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function |
| Q58029968 | A preliminary study on the effect of hormone replacement therapy on peripheral flow velocity in postmenopausal women |
| Q84458613 | A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored |
| Q73364939 | Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors |
| Q74808997 | Acute effect of estrogen on metabolic coronary vasodilator responses to atrial pacing in postmenopausal women |
| Q44142562 | Acute effects of 17beta-estradiol on left internal mammary graft after coronary artery bypass grafting |
| Q73835680 | Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men |
| Q43748772 | Anti-ischemic effect of chronic oestrogen replacement therapy alone or in combination with medroxyprogesterone acetate in different replacement schemes |
| Q35028892 | Antiarrhythmic effect and its underlying ionic mechanism of 17beta-estradiol in cardiac myocytes |
| Q33709262 | Antiatherosclerotic activity of drugs in relation to nitric oxide function |
| Q33731648 | Assessment and treatment of endothelial dysfunction in humans |
| Q39027656 | Association between plasma leptin and adiponectin levels and diastolic function in the general population. |
| Q43573541 | Attenuation of endothelin-1 induced vasoconstriction by 17beta estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart disease |
| Q51776462 | Beneficial effects of isometric strength training on endothelial dysfunction in rats. |
| Q33984342 | Cardioprotective effects of ovarian hormones and the HERS in perspective |
| Q37688153 | Cardiovascular disease is preventable among women |
| Q31797579 | Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Investigators. |
| Q36872073 | Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator |
| Q54068450 | Cardiovascular hemodynamics with increasing exercise intensities in postmenopausal women. |
| Q33742238 | Cardiovascular pharmacology of hormone replacement therapy |
| Q46742329 | Cardiovascular stress response and coronary artery disease: evidence of an adverse postmenopausal effect in women. |
| Q46741297 | Circulating nitric oxide levels in galactorrheic, hyperprolactinemic, amenorrheic women |
| Q77580502 | Coadministration of nomegestrol acetate does not diminish the beneficial effects of estradiol on coronary artery dilator responses in nonhuman primates (Macaca fascicularis) |
| Q73744496 | Comparison of coronary flow reserve between focal and diffuse vasoconstriction induced by ergonovine in patients with vasospastic angina |
| Q37138852 | Contraceptive hormone use and cardiovascular disease |
| Q35739686 | Coronary Microvascular Function and Beyond: The Crosstalk between Hormones, Cytokines, and Neurotransmitters |
| Q41457645 | Coronary risk factors, endothelial function, and atherosclerosis: a review |
| Q46909294 | Coronary vasomotor reactivity among normotensive african and white american subjects with chest pain |
| Q71697421 | Current estrogen-progestin and estrogen replacement therapy in elderly women: association with carotid atherosclerosis. CHS Collaborative Research Group. Cardiovascular Health Study |
| Q41582111 | Detection of coronary artery disease in women with use of stress single-photon emission computed tomography myocardial perfusion imaging |
| Q35976612 | ER Alpha Rapid Signaling Is Required for Estrogen Induced Proliferation and Migration of Vascular Endothelial Cells |
| Q77794126 | Effect of N-acetylcysteine on vascular endothelium function in aorta from oophorectomized rats |
| Q35028370 | Effect of acute and long-term treatment with 17-beta-estradiol on the vasomotor responses in the rat aorta |
| Q50858213 | Effect of estradiol on rat ileum. |
| Q34964020 | Effect of estrogen on endothelial function and angiogenesis |
| Q44427250 | Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study |
| Q43748764 | Effect of hormone replacement therapy on lipids in perimenopausal and early postmenopausal women |
| Q74572847 | Effect of hormone replacement therapy on the electrocardiographic response to exercise |
| Q73151528 | Effect of intracoronary estrogen on coronary collateral blood flow velocity |
| Q58920582 | Effect of prolonged administration of transdermal estradiol on flow-mediated endothelium-dependent and endothelium-independent vasodilation in healthy postmenopausal women |
| Q73227410 | Effect on survival of estrogen replacement therapy after coronary artery bypass grafting |
| Q64986485 | Effects of a single dose of oral estrogen on left ventricular diastolic function in hypertensive postmenopausal women with diastolic dysfunction. |
| Q43852476 | Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina |
| Q51561274 | Effects of age, gender and metabolic factors on endothelium-dependent vasodilation: a population-based study. |
| Q54019405 | Effects of estrogen therapy on arterial resistance and pulsatility in postmenopausal women. |
| Q43634449 | Effects of oophorectomy on functional properties of resistance arteries isolated from the cancellous bone of the rabbit femur |
| Q74598225 | Effects of withdrawal of chronic estrogen therapy on brachial artery vasoreactivity in women with coronary artery disease |
| Q36296225 | Endocrine therapy--current benefits and limitations |
| Q37362719 | Endothelial dysfunction: a potential tool in gender related cardiovascular disease |
| Q40861583 | Endothelial dysfunction: implications for therapy of cardiovascular diseases |
| Q37196296 | Essential role of the 90-kilodalton heat shock protein in mediating nongenomic estrogen signaling in coronary artery smooth muscle |
| Q34081355 | Estradiol increases angiotensin II type 1 receptor in hearts of ovariectomized rats |
| Q35060761 | Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase. |
| Q44712587 | Estradiol-induced expression of N(+)-K(+)-ATPase catalytic isoforms in rat arteries: gender differences in activity mediated by nitric oxide donors |
| Q40977120 | Estrogen acutely increases peripheral blood flow in postmenopausal women. |
| Q53028018 | Estrogen after ischemic stroke: clinical basis and design of the Women's Estrogen for Stroke Trial. |
| Q40434453 | Estrogen and cardiovascular function after menopause |
| Q71933401 | Estrogen and coronary artery disease in postmenopausal women |
| Q33936813 | Estrogen and oxidative stress: A novel mechanism that may increase the risk for cardiovascular disease in women |
| Q34963989 | Estrogen and vascular function |
| Q33898014 | Estrogen as a neuroprotectant in stroke |
| Q32057813 | Estrogen improves endothelial function |
| Q48354150 | Estrogen increases cGMP in selected brain regions and in cerebral microvessels |
| Q50529691 | Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: effects on migration and proliferation of vascular smooth muscle cells. |
| Q35766714 | Estrogen inhibits the response-to-injury in a mouse carotid artery model |
| Q36782062 | Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice |
| Q74137301 | Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies |
| Q33836086 | Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen |
| Q64355675 | Estrogen receptor subcellular localization and cardiometabolism |
| Q74800839 | Estrogen replacement reverses endothelial dysfunction in postmenopausal women |
| Q34557438 | Estrogen replacement therapy and cardioprotection: mechanisms and controversies |
| Q73048707 | Estrogen replacement therapy and exercise performance in postmenopausal women with coronary artery disease |
| Q77178149 | Estrogen replacement therapy and outcome of coronary balloon angioplasty in postmenopausal women |
| Q36835892 | Estrogen-induced improvement in coronary flow responses during atrial pacing in relation to endothelin-1 levels in postmenopausal women without coronary disease |
| Q35540815 | Estrogens ,homocysteine ,vasodilatation and menopause: basic mechanisms ,interactions and clinical implications |
| Q41386331 | Estrogens, menopause, and coronary artery disease |
| Q47703245 | Estrogens, progestins, and coronary artery reactivity in atherosclerotic monkeys |
| Q34447854 | Ethinyl estradiol-to-desogestrel ratio impacts endothelial function in young women |
| Q77295103 | Excessive vasoconstriction after stress by the aging kidney: inadequate prostaglandin modulation of increased endothelin activity |
| Q71907145 | Exercise echocardiography in postmenopausal hormone users with mild systemic hypertension |
| Q27001986 | G-protein-coupled estrogen receptor as a new therapeutic target for treating coronary artery disease |
| Q83207630 | Gender and cardiovascular disease recent insights |
| Q33716546 | Gender and vascular reactivity |
| Q35558556 | Gender differences in predictors of left ventricular myocardial relaxation in non-obese, healthy individuals |
| Q71215430 | Gonadotropin-releasing hormone agonist-induced hypoestrogenism and blood flows in cerebral arteries |
| Q37383757 | Growth factor activation of the estrogen receptor in vascular cells occurs via a mitogen-activated protein kinase-independent pathway |
| Q33843646 | Hormone replacement therapy and coronary heart disease. A new debate |
| Q43813819 | Hormone replacement therapy and endothelial function. Results of a randomized controlled trial in healthy postmenopausal women |
| Q34107469 | Hormone replacement therapy in the prevention and treatment of atherosclerosis |
| Q44304778 | Hormone replacement therapy increases renal kallikrein excretion in healthy postmenopausal women |
| Q34267973 | Hormones after menopause? |
| Q34675309 | Hormones and heart disease: what we thought, what we have learned, what we still need to know |
| Q38287914 | Human vascular smooth muscle cells express an estrogen receptor isoform |
| Q44307928 | Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study |
| Q43514045 | Interaction of gender and exercise training: vasomotor reactivity of porcine skeletal muscle arteries |
| Q44961037 | Isoflavones improve vascular reactivity in post-menopausal women with hypercholesterolemia |
| Q44753295 | L-arginine ameliorates the abnormal sympathetic response of the dysfunctional human coronary microvasculature |
| Q74304946 | Large-scale hormone replacement therapy and life expectancy: results from an international comparison among European and North American populations |
| Q44454497 | Lipid profiles and endothelial function with low-dose hormone replacement therapy in postmenopausal women at risk for coronary artery disease: a randomized trial |
| Q46944678 | Long-term effects of low-dose 17beta-estradiol plus dydrogesterone on 24-h ambulatory blood pressure in healthy postmenopausal women: a 1-year, randomized, prospective study |
| Q73132681 | Long-term estrogen therapy abolishes acute estrogen-induced coronary flow augmentation in postmenopausal women |
| Q50952179 | Long-term estrogen therapy improves vascular function in male to female transsexuals. |
| Q40927324 | Looking beyond the dogma of genomic steroid action: insights and facts of the 1990s |
| Q35041901 | Mechanisms of 17 beta-oestradiol induced vasodilatation in isolated pressurized rat small arteries. |
| Q34132682 | Mechanisms of estrogen action in the cardiovascular system |
| Q74379872 | Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins |
| Q44048875 | Medroxyprogesterone acetate does not antagonize estrogen-induced increases in endothelium-dependent vasodilation: potential clinical implications |
| Q74413874 | Menopause and hormone replacement therapy |
| Q37504948 | Mitochondrial p38β and manganese superoxide dismutase interaction mediated by estrogen in cardiomyocytes |
| Q34062334 | Modification of blood pressure in postmenopausal women: role of hormone replacement therapy |
| Q35823854 | Myocardial Infarction in a Premenopausal Woman on Leuprolide Therapy |
| Q44445541 | Myocardial infarction during menses: lessons from trials and errors |
| Q90324610 | Myocardial infarction in a premenopausal woman with a decreased serum estrogen level due to leuprorelin acetate |
| Q71111843 | Nitric oxide production by coronary conductance and resistance vessels in hypercholesterolemia patients |
| Q40405202 | Nitric oxide-based possibilities for pharmacotherapy |
| Q40979557 | Non-genomic effects of estrogen and the vessel wall |
| Q34868756 | Non-nuclear estrogen receptor signaling in the endothelium |
| Q35038285 | Nongenomic actions of steroid hormones |
| Q33610185 | Nongenomic steroid actions: fact or fantasy? |
| Q36979964 | Noninvasive assessment of coronary microvascular function in women at risk for ischaemic heart disease |
| Q37048199 | Normal Reference Values for Doppler Echocardiography: Influences of Ageing, Gender and Ethnicity. |
| Q36534741 | Novel aspects of endothelium-dependent regulation of vascular tone. |
| Q33858417 | Novel role of estrogen receptors in vascular endothelium |
| Q47311488 | Nuclear and Membrane Actions of Estrogen Receptor Alpha: Contribution to the Regulation of Energy and Glucose Homeostasis. |
| Q41107941 | Oestrogen receptors and cardiovascular disease |
| Q58294084 | Oestrogen replacement therapy and coronary heart disease |
| Q58167003 | Oestrogens Attenuate Abnormal Coronary Vasoreactivity in Postmenopausal Women |
| Q33916551 | Phytoestrogens and cardiovascular health. |
| Q72333937 | Postischemic cerebral blood flow recovery in the female: effect of 17 beta-estradiol |
| Q33683302 | Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection |
| Q33757741 | Postmenopausal hormone therapy, SERMs, and coronary heart disease in women |
| Q41723402 | Postmenopausal hormone therapy. Is it useful for coronary prevention? |
| Q34232000 | Postmenopausal oestrogen replacement therapy and atherosclerosis: can current compounds provide cardiovascular protection? |
| Q33857984 | Prevention of coronary heart disease. Part II. Secondary prevention, detection of subclinical disease, and emerging risk factors |
| Q78228774 | Progesterone modulates estradiol actions: acute effects at physiological concentrations |
| Q33843668 | Putting prevention into daily practice |
| Q44489365 | Raloxifene, conjugated oestrogen and endothelial function in postmenopausal women |
| Q44208463 | Regional differences in the effect of oestrogen on vascular tone in isolated rabbit arteries |
| Q35026485 | Regulation of bradykinin B2-receptor expression by oestrogen |
| Q56945461 | Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions |
| Q43978477 | Relation of baseline forearm vasodilator reserve to vascular endothelial response to estrogen replacement therapy in healthy postmenopausal women |
| Q73746088 | Retinopathy identifies marked restriction of coronary flow reserve in patients with diabetes mellitus |
| Q41095098 | Role of insulin resistance in the pathogenesis of NIDDM. |
| Q36854152 | Sex hormones and the cardiovascular system: effects on arterial function in women. |
| Q41540436 | Sex hormones and vascular reactivity |
| Q46713736 | Sexual dimorphism in rabbit aortic endothelial function under acute hyperglycemic conditions and gender-specific responses to acute 17beta-estradiol |
| Q54150284 | Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms. |
| Q73857168 | Short-term estrogen administration ameliorates dobutamine-induced myocardial ischemia in postmenopausal women with coronary artery disease |
| Q50857888 | Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud's phenomenon. |
| Q37371073 | Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits |
| Q71952778 | Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques |
| Q34465352 | Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin |
| Q24317626 | Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha |
| Q46493833 | Testosterone and nandrolone sensitization of brain anteroventral area of third ventricle to hypertonic NaCl-induced sympathetic response |
| Q46320355 | Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta |
| Q35739598 | The Effect of Eqoul, a Metabolite of Isoflavone, on Endothelial Cell-independent Vasodilatation of Human Uterine Artery In Vitro |
| Q41666188 | The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report |
| Q39448830 | The cardiovascular safety of triphasic contraceptive steroids |
| Q33653638 | The effect of 17 beta-estradiol on intracellular calcium homeostasis in human endothelial cells |
| Q71832332 | The effect of oophorectomy on mechanical properties of rabbit cerebral and coronary isolated small arteries |
| Q74525431 | The effect of tamoxifen and transdermal 17beta-estradiol on cerebral arterial vessels: a randomized controlled study |
| Q44019594 | The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women |
| Q73272009 | The effects of 17beta-estradiol on ectopic rhythm in human atrial strips |
| Q41507873 | The effects of hormone replacement therapy on coronary heart disease |
| Q34134001 | The endothelium: a gynecological and obstetric point of view. |
| Q44670817 | The influence of sex hormones on ocular blood flow in women |
| Q34504839 | The medicalization of menopause: critique and consequences |
| Q39462339 | The menopause and the cardiovascular system |
| Q35617189 | The role of estrogen in cardiovascular disease |
| Q85219201 | VWF and ADAMTS13 behavior in estradiol-treated HUVEC |
| Q34224777 | Vascular effects of hormones |
| Q35155324 | Vasorelaxant effect of 17α-ethynylestradiol on human saphenous vein. |
| Q33801935 | Who Should Receive Hormone Replacement Therapy? |
| Q35124783 | Whole grains protect against atherosclerotic cardiovascular disease |
| Q71529814 | Why cardiologists should be interested in estrogen |
| Q44264779 | Women's angiographic vitamin and estrogen trial: design and methods |
| Q73186314 | [A clinical screening can predict coronary artery disease in women] |
| Q78784685 | [Androgens in menopausal women] |
| Q54138041 | [Therapeutic options for improvement of myocardial perfusion in coronary atherosclerosis]. |
Search more.